查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1970010

全球體外受精模板市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global In-Vitro Transcription Templates Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

體外移植模板市場預計將從 2025 年的 4.299 億美元成長到 2034 年的 22.3654 億美元，2026 年至 2034 年的複合年成長率為 20.11%。

受基因研究日益受到重視以及生物技術進步的推動，全球體外轉錄模板市場正經歷強勁成長。這些模板對於實驗室中RNA分子的合成至關重要，並廣泛應用於疫苗研發、基因治療和分子生物學研究。近年來，對基於mRNA的疫苗和療法的需求不斷成長，顯著加速了市場的擴張。

研究機構和製藥公司正大力投資先進的基因技術。個人化醫療的快速發展以及罕見疾病和癌症相關研究計劃的增加，推動了對可靠轉錄模板的需求。政府對生命科學研究的資助以及生技公司之間的合作也是促進全球市場成長的因素。

展望未來，合成生物學和藥物研發領域應用的不斷拓展預計將對市場產生積極影響。模板設計和製造方法的持續創新將帶來效率提升和成本降低。隨著生物技術的進步和mRNA療法的日益普及，體外轉錄模板市場預計將在全球範圍內持續成長並迎來新的發展機會。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球體外受精模板市場：依產品類型分類

  • 市場分析、洞察與預測
  • DNA模板
  • RNA模板
  • 模板和轉印套件
  • 其他產品類型

第5章 全球體外轉錄模板市場：依疾病分類

  • 市場分析、洞察與預測
  • 癌症
  • 感染疾病
  • 與文明病
  • 遺傳性疾病
  • 其他疾病

第6章：全球體外轉錄模板市場：依治療方法

  • 市場分析、洞察與預測
  • 疫苗
  • 治療方法

第7章 全球體外轉錄模板市場：依研究階段分類

  • 市場分析、洞察與預測
  • 探索性的
  • 臨床

第8章：全球體外移植模板市場：依最終用途分類

  • 市場分析、洞察與預測
  • 生物技術和製藥公司
  • 學術研究機構
  • 受託研究機構

第9章 全球體外轉錄模板市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Agilent Technologies Inc
    • Bio-Synthesis Inc
    • Bio-Rad Laboratories Inc
    • Cinven Limited
    • Danaher Corporation
    • Enzynomics Co Ltd
    • Enzo Biochem Inc
    • F. Hoffmann-La Roche Ltd
    • Illumina Inc
    • LGC Limited
    • Merck KGaA
簡介目錄
Product Code: VMR112110702

The In-Vitro Transcription Templates Market size is expected to reach USD 2236.54 Million in 2034 from USD 429.90 Million (2025) growing at a CAGR of 20.11% during 2026-2034.

The Global In-Vitro Transcription Templates Market is experiencing strong growth due to the increasing focus on genetic research and biotechnology advancements. These templates are essential for synthesizing RNA molecules in laboratory settings, which are widely used in vaccine development, gene therapy, and molecular biology studies. The growing demand for mRNA-based vaccines and therapeutics has significantly accelerated market expansion in recent years.

Research institutions and pharmaceutical companies are investing heavily in advanced genetic technologies. The rapid progress in personalized medicine and the increasing number of research projects related to rare diseases and cancer are driving demand for reliable transcription templates. Government funding for life sciences research and collaborations between biotech firms are also supporting the market's growth globally.

In the future, the market is expected to benefit from expanding applications in synthetic biology and drug discovery. Continuous innovation in template design and production methods will improve efficiency and reduce costs. As biotechnology continues to evolve and mRNA therapies gain wider acceptance, the in-vitro transcription templates market is likely to witness sustained growth and new opportunities worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • DNA Templates
  • RNA Templates
  • Templates And Transcription Kits
  • Other Product Types

By Disease

  • Cancer
  • Infectious Disease
  • Lifestyle Disease
  • Genetic Disease
  • Other Diseases

By Treatment

  • Vaccine
  • Therapeutic

By Research Stage

  • Exploratory
  • Clinical

By End-Use

  • Biotechnology And Pharmaceutical Companies
  • Academic And Research Institutes
  • Contract Research Organizations

COMPANIES PROFILED

  • Agilent Technologies Inc, BioSynthesis Inc, BioRad Laboratories Inc, Cinven Limited, Danaher Corporation, Enzynomics Co Ltd, Enzo Biochem Inc, F HoffmannLa Roche Ltd, Illumina Inc, LGC Limited, Merck KGaA
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. DNA Templates Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. RNA Templates Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Templates And Transcription Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Other Product Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET: BY DISEASE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Disease
  • 5.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Infectious Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Lifestyle Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Genetic Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Other Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET: BY TREATMENT 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Treatment
  • 6.2. Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Therapeutic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET: BY RESEARCH STAGE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Research Stage
  • 7.2. Exploratory Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Clinical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET: BY END-USE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End-use
  • 8.2. Biotechnology And Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET: BY REGION 2022-2034(USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Product Type
    • 9.2.2 By Disease
    • 9.2.3 By Treatment
    • 9.2.4 By Research Stage
    • 9.2.5 By End-use
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Product Type
    • 9.3.2 By Disease
    • 9.3.3 By Treatment
    • 9.3.4 By Research Stage
    • 9.3.5 By End-use
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Product Type
    • 9.4.2 By Disease
    • 9.4.3 By Treatment
    • 9.4.4 By Research Stage
    • 9.4.5 By End-use
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Product Type
    • 9.5.2 By Disease
    • 9.5.3 By Treatment
    • 9.5.4 By Research Stage
    • 9.5.5 By End-use
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 South East Asia
    • 9.5.11 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Product Type
    • 9.6.2 By Disease
    • 9.6.3 By Treatment
    • 9.6.4 By Research Stage
    • 9.6.5 By End-use
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Agilent Technologies Inc
    • 11.2.2 Bio-Synthesis Inc
    • 11.2.3 Bio-Rad Laboratories Inc
    • 11.2.4 Cinven Limited
    • 11.2.5 Danaher Corporation
    • 11.2.6 Enzynomics Co Ltd
    • 11.2.7 Enzo Biochem Inc
    • 11.2.8 F. Hoffmann-La Roche Ltd
    • 11.2.9 Illumina Inc
    • 11.2.10 LGC Limited
    • 11.2.11 Merck KGaA